Activities
PMAC is committed to advancing cancer research through collaborative, multi-institutional efforts that generate robust, high-quality data. Our work is powered by a comprehensive, well-annotated database that integrates clinical, pathological, molecular, and treatment information, along with patient outcomes, to support precision medicine initiatives. Currently, this resource includes data from patients diagnosed with breast cancer who have undergone liquid biopsy testing.
The database continues to expand as new patients are enrolled across participating institutions, strengthening the foundation for impactful research.
PMAC’s scientific productivity is reflected in its consistent presence at major international conferences and numerous publications in high-impact, peer-reviewed journals. These contributions have significantly advanced the understanding of breast cancer biology, mechanisms of treatment resistance, and the clinical utility of liquid biopsy technologies.
PMAC at a Glance
11
Research Articles
12
Academic Institutions
3,000+
_Page_01.jpg)
